Announcements Trials
Browse Landscape

Phase

Phase 4 2

Status

Completed 13Unknown 3Withdrawn 1Terminated 1Recruiting 1

Sponsor Class

OTHER 3

Study Type

Interventional 2Observational 1

Sponsor

Conditions

Arthritis, Rheumatoid 3Spondylitis, Ankylosing 1Infections 1Autoimmune Diseases 1

Interventions

Infliximab 4Etanercept 4Adalimumab 3tocilizumab 1golimumab 1entecavir 1Tumor Necrosis Factor Inhibitors 1Prednisone 1Observation 1Licensure 1Leflunomide 1Glucocorticoids 1Dietary Fiber 1Antirheumatic Agents 1Anti-Inflammatory Agents, Non-Steroidal 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Unknown × Arthritis, Rheumatoid × Adalimumab × Clear all
NCT01793519 2024-02-28

STARA

Georgetown University

Phase 4 Unknown
290 enrolled

Arthritis, Rheumatoid, Autoimmune Diseases

NCT04115423 2020-09-10

A Retrospective Cohort Study on the Risk of Serious Infections in Rheumatoid Arthritis Patients Receiving Tocilizumab

Sungkyunkwan University

Unknown
9,508 enrolled

Arthritis, Rheumatoid, Infections

NCT02878161 2016-08-25

Predictability Studies on the Efficacy of TNF-α Inhibitors in Chinese RA From "Real World"

Central South University

Phase 4 Unknown
240 enrolled

Arthritis, Rheumatoid

Data powered by HemOnc (CC BY 4.0) Colophon âš¡